Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000234201

Medchemexpress LLC Bi-1347 | 2163056-91-3 | ≥98.0% | 1 ML
SDP

Catalog No. 5000234201
Encompass_Preferred

Bi-1347 is a potent, selective small-molecule inhibitor of cyclin-dependent kinase 8 (CDK8), reported IC50 ≈ 1-1.1 nM. It has demonstrated antitumoral activity in preclinical models and is used as a research tool to probe CDK8/19 biology. Supplied as a 10 mM solution in DMSO for in vitro studies; research use only.

  • Potent CDK8 inhibitor (IC50 ≈ 1-1.1 nM)
  • Shows antitumoral activity in preclinical models
  • Also active against CDK19 with high selectivity
  • Provided as 10 mM solution in DMSO for in vitro experiments
  • Intended for research use only; not for human therapeutic use

Catalog No. 50-002-34201 Supplier Medchemexpress LLC Supplier No. HY12035010MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bi-1347 is a potent, selective small-molecule inhibitor of cyclin-dependent kinase 8 (CDK8), reported IC50 ≈ 1-1.1 nM. It has demonstrated antitumoral activity in preclinical models and is used as a research tool to probe CDK8/19 biology. Supplied as a 10 mM solution in DMSO for in vitro studies; research use only.

  • Potent CDK8 inhibitor (IC50 ≈ 1-1.1 nM)
  • Shows antitumoral activity in preclinical models
  • Also active against CDK19 with high selectivity
  • Provided as 10 mM solution in DMSO for in vitro experiments
  • Intended for research use only; not for human therapeutic use

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.